AGEX THERAPEUTICS INC (AGE)
US00848H2076 - Common Stock
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -14.05M | -10.46M | -8.58M | -10.87M | -12.15M | |||
| Depreciation Amortization | 130.00K | 130.00K | 130.00K | 1.26M | 650.00K | |||
| Change In Working Capital | 910.00K | 330.00K | -880.00K | -60.00K | -410.00K | |||
| Interest Paid | 30.00K | 10.00K | 10.00K | 10.00K | 10.00K | |||
| Other non cash items | 5.94M | 4.06M | 1.48M | 1.85M | 1.76M | |||
| OPERATING CASH FLOW | -7.07M | -5.94M | -7.86M | -7.82M | -10.16M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | 0.00 | -20.00K | -640.00K | |||
| Other Investing Activity | -10.00M | 0.00 | 670.00K | N/A | 280.00K | |||
| INVESTING CASH FLOW | -10.00M | 0.00 | 670.00K | -20.00K | -360.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 17.00M | 6.00M | 7.00M | 6.12M | 1.77M | |||
| Stock Issued/Repurchased | N/A | 0.00 | 500.00K | N/A | 4.50M | |||
| Other Financing Activity | N/A | 0.00 | -250.00K | -160.00K | N/A | |||
| FINANCING CASH FLOW | 17.00M | 6.00M | 7.25M | 5.96M | 6.27M | |||
| Exchange Rate Effect | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| CHANGE IN CASH | -70.00K | 60.00K | 60.00K | -1.88M | -4.25M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.07M | -5.94M | -7.86M | -7.82M | -10.16M | |||
| Capital Expenditure | N/A | N/A | 0.00 | -20.00K | -640.00K | |||
| FREE CASH FLOW | -7.07M | -5.94M | -7.86M | -7.84M | -10.80M | |||
All data in USD